Medication info

Donepezil Sublingual Tablet 10mg (Donepezil Hydrochloride Hydrate)

Prescription medicationOrally disintegrating TabletOralExpired
Ingredient · strength
Donepezil Hydrochloride Hydrate›10.43mg / 1 tablet
Manufacturer / importer
Hanfung Pharmaceutical Co., Ltd.
Appearance
Yellow round sublingual tablet
Packaging
30 tablets/PTP [(10 tablets/PTP packaging x 3)]
Approval status
Expired

MFDS item code 201908247 · Approved 2019.12.05

This product's status changed to Expired on 2024.12.05. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of symptoms of Alzheimer's-type dementia
Who takes it
Adults · Children
Adult dose
Administer 5 mg of donepezil hydrochloride once daily at bedtime. If sleep disturbances such as unusual dreams, nightmares, or insomnia occur, administration of this medicine in the morning may be considered. Since donepezil concentrations reach steady state 15 days after administration and the frequency of adverse reactions may be affected by the rate of dose increase, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with caution for gastrointestinal adverse reactions. When administration of this medicine is discontinued, its effects gradually diminish, and no rebound effect occurs with abrupt discontinuation. This medicine is an orally disintegrating tablet that can be placed on the tongue and allowed to dissolve, and taken without water. Female patients aged 85 years or older who are underweight: Careful monitoring is required because adverse reactions occur more frequently. Underweight elderly women should not take more than 5 mg daily.
Child dose
There is no experience with use in children.

Ingredients

Manufacturer
Hanfung Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of symptoms of Alzheimer's-type dementia

  • Symptoms of Alzheimer’s type dementia
View approved original text

Used for the treatment of symptoms of Alzheimer’s type dementia.

How to take

Adult dose

Administer 5 mg of donepezil hydrochloride once daily at bedtime. If sleep disturbances such as unusual dreams, nightmares, or insomnia occur, administration of this medicine in the morning may be considered. Since donepezil concentrations reach steady state 15 days after administration and the frequency of adverse reactions may be affected by the rate of dose increase, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with caution for gastrointestinal adverse reactions. When administration of this medicine is discontinued, its effects gradually diminish, and no rebound effect occurs with abrupt discontinuation. This medicine is an orally disintegrating tablet that can be placed on the tongue and allowed to dissolve, and taken without water. Female patients aged 85 years or older who are underweight: Careful monitoring is required because adverse reactions occur more frequently. Underweight elderly women should not take more than 5 mg daily.

Child dose

There is no experience with use in children.

Precautions

This medication should not be administered to patients with phenylketonuria, a genetic disorder, as aspartame, the artificial sweetener contained in this medication, is metabolized to phenylalanine in the body. Daily intake of aspartame should be limited to less than 40mg/kg as recommended by WHO, and only the minimum amount necessary should be used. For example, for a 60kg adult, the maximum daily dosage is 2.4g. Patients with allergic reactions to the ingredients of this medication, or hypersensitivity to donepezil hydrochloride or piperidine derivatives, should not take this medication. Furthermore, pregnant women, women of childbearing potential, and nursing mothers should avoid using this medication unless strictly necessary. Caution should be taken when administering this medication to patients with heart diseases, especially those with bradycardia syndrome or cardiac conduction disorders, as it may stimulate the vagus nerve, leading to bradycardia or arrhythmias. Patients taking non-steroidal anti-inflammatory drugs or those with a history of peptic ulcers should be cautious as this medication may increase gastric acid secretion, potentially exacerbating symptoms. Patients with asthma or a history of obstructive pulmonary disease should be careful since this medication may cause bronchial smooth muscle contraction and increase mucus secretion, worsening symptoms. Patients with Parkinson’s disease or extrapyramidal disorders may find that this medication exacerbates symptoms by stimulating cholinergic nerves. This medication contains Yellow No. 4 (Tartrazine), and patients with allergies or hypersensitivity to this ingredient should use it cautiously. While taking this medication, there may be serious side effects such as cardiac-related abnormal symptoms (fainting, bradycardia, cardiac blockage, etc.), gastrointestinal bleeding, liver function abnormalities, cerebrovascular issues, extrapyramidal disorders, neuroleptic malignant syndrome, rhabdomyolysis, shortness of breath, acute pancreatitis, acute renal failure, and unexplained sudden death; therefore, any unusual symptoms should promptly be discussed with a doctor. Additionally, this medication may cause various side effects such as diarrhea, nausea, vomiting, loss of appetite, dizziness, insomnia, headache, fatigue, and muscle pain, so symptoms should be carefully monitored during use. This medication is approved solely for the treatment of Alzheimer’s type dementia and should not be used for other forms of dementia or memory disorders. Treatment should be conducted under the supervision of an experienced physician, and the treatment's effectiveness should be regularly evaluated. Patients with heart diseases or electrolyte abnormalities may require cardiac monitoring when taking this medication. As dizziness or fatigue may occur while driving or operating machinery, caution is advised. It is generally recommended that women who are pregnant or breastfeeding avoid using this medication, and if necessary, they should consult a specialist. This medication may interact with various drugs; therefore, it is crucial to inform a doctor or pharmacist if taking other medications. In case of overdose, symptoms such as nausea, vomiting, sweating, bradycardia, respiratory depression, and seizures may occur, necessitating immediate medical attention. This medication is taken orally in dissolvable tablet form, and it should be completely dissolved on the tongue before swallowing with saliva or water. For storage, keep it in a tightly closed container to prevent air ingress and store it at room temperature between 1°C and 30°C. Proper storage will help to maintain the effectiveness of the medication.

Side effects

  • fainting
  • bradycardia
  • heart block
  • QT interval prolongation
  • myocardial infarction
  • heart failure
  • peptic ulcer
  • perforated duodenal ulcer
  • gastrointestinal bleeding
  • hepatitis
Show 126 more
  • liver dysfunction
  • jaundice
  • cerebral seizure
  • cerebral hemorrhage
  • cerebrovascular disorders
  • motor dysfunction
  • ataxia
  • movement disorders
  • dystonia
  • tremor
  • involuntary movement
  • gait disturbance
  • abnormal posture
  • speech disorder
  • akinetic mutism
  • extreme muscle rigidity
  • dysphagia
  • tachycardia
  • blood pressure fluctuations
  • sweating
  • myalgia
  • weakness
  • dyspnea
  • acute pancreatitis
  • acute renal failure
  • sudden death
  • cold
  • loss of appetite
  • hallucinations
  • agitation
  • aggressive behavior
  • anxiety disorder
  • insomnia
  • drowsiness
  • increased libido
  • talkativeness
  • mania
  • nightmares
  • nervous sensitivity
  • nonsensical speech
  • delusions
  • depression
  • confusion
  • apathy
  • hyperactivity
  • hypersexuality
  • dizziness
  • tremor
  • seizure
  • stupor
  • thoracic rigidity
  • palpitations
  • sinoatrial block
  • atrioventricular block
  • hypertension
  • hypotension
  • atrial fibrillation
  • torsades de pointes
  • diarrhea
  • nausea
  • vomiting
  • abdominal disorders
  • gastric-duodenal ulcer
  • constipation
  • salivation
  • fecal incontinence
  • liver disorder
  • rash
  • itching
  • muscle cramps
  • myalgia
  • urinary incontinence
  • frequent urination
  • urinary retention
  • headache
  • fatigue
  • pain
  • toothache
  • facial flushing
  • lethargy
  • asthenia
  • edema
  • fever
  • decreased body temperature
  • reduced hematocrit
  • leukopenia
  • anemia
  • thrombocytopenia
  • cardiac arrest
  • urinary tract infection
  • dehydration
  • hyperlipidemia
  • eczema
  • hostility
  • irritability
  • drowsiness
  • depression
  • confusion
  • emotional instability
  • personality abnormality
  • skin ulcer
  • psoriasis
  • skin discoloration
  • herpes zoster
  • dry skin
  • urticaria
  • vesicular rash
  • conjunctivitis
  • glaucoma
  • visual disturbances
  • ear pain
  • tear abnormalities
  • cystitis
  • hematuria
  • diabetes
  • vaginitis
  • urination disorders
  • proteinuria
  • petechiae
  • abnormal dreams
  • anxiety
  • cholecystitis
  • hemolytic anemia
  • hyponatremia
  • neuroleptic malignant syndrome
  • pancreatitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air ingress and at a temperature between 1°C and 30°C. Proper storage will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

Yellow round sublingual tablet

Package unit

30 tablets/PTP [(10 tablets/PTP packaging x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.